Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Visualant Wins Fourth Patent on ChromaID Technology Using Exclusive Spectral Pattern Matching Technique  Join our daily free Newsletter

MENAFN - - 11/1/2012 9:04:48 AM

Digg This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story.aspx%3fstoryid%3d744180f5-96f6-4e77-b343-efe2dcc5d75d%26src%3dMWHEAD Share This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story.aspx%3fstoryid%3d744180f5-96f6-4e77-b343-efe2dcc5d75d%26src%3dMWHEAD Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!


Visualant Wins Fourth Patent on ChromaID Technology Using Exclusive Spectral Pattern Matching Technique

SEATTLE, Nov 1, 2012 (Menafn - GlobeNewswire via COMTEX) --via PRWEB - Visualant, Inc. VSUL -- an industry-leading provider of chromatic-based identification and diagnostic solutions, announced today that it received its fourth patent on its ChromaID(TM) technology that uses an exclusive Spectral Pattern Matching(TM) ("SPM") technique. The latest patent further validates the company's vision to introduce more efficient security and authentication methods into the marketplace, and comes shortly after Visualant and its investment partner Sumitomo Precision Products Co., Ltd. ("SPP") showcased a prototype of its Cyclops 6(TM) ChromaID hand-held scanner in Japan last month.

Future devices embedded with ChromaID technology can read and record natural chromatic markers by structuring light onto a substance, through a liquid or gas, or off a surface. Once scanned, the technology captures the reflected light in a simple Photodiode and provides a unique ChromaID profile. The ChromaID profile can be matched against existing databases to identify, detect, or diagnosis markers invisible to the human eye.

Visualant Founder and CEO Ron Erickson believes ChromaID technology will usher in new angles to protect consumer products, currencies, pharmaceuticals, and a wide variety of products by bringing the power of spectral analysis from the lab and into the field. Erickson states, "Our technology adds another authentication layer to tools used by government and industrial entities who grapple with the identification and security challenges that impact our society at large."

ChromaID technology was developed in conjunction with renowned research scientists, Drs. Tom Furness and Brian Schowengerdt. Together, they have forged a unique proprietary approach to mapping color at the photon level and using that mapping as a basis for authentication and diagnostics. In conjunction with the stellar work being done in the lab, the company continues to pursue an aggressive patent strategy to protect its unique intellectual property.

Drs. Furness and Schowengerdt and their laboratory development team brought a generation of experience to the Visualant SPM development process. Dr. Furness is known in many circles as the "Father of Virtual Reality." Dr. Schowengerdt is an internationally renowned leader in the field of color perception.

The patent issued by the United States Office of Patents and Trademarks is US Patent No. 8,285,510 B2 and is entitled "Method, Apparatus and Article To Facilitate Distributed Evaluation of Object Using Electromagnetic Energy."

Ron Erickson, Visualant Founder and CEO, stated, "It's an honor to now hold four patents covering our ChromaID technology. We expect more patents to be issued as we build the intellectual property foundation for Visualant's business and move into the marketplace with diverse applications of our SPM technology."

About Visualant, Inc.

Visualant is a public company whose shares trade under the stock symbol, VSUL. The Visualant Spectral Pattern Matching(TM) technology directs structured light onto a substance, through a liquid/gas, or off a surface, to capture a unique ChromaID. When matched against existing databases, a ChromaID(TM) can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID(TM) scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab--based tests.

Visualant entered into a one year Joint Development Agreement on May 31, 2012 with Sumitomo Precision Products Co., Ltd. ("SPP"), which focuses on the commercialization of the SPM technology and a License Agreement providing SPP with an exclusive license of the SPM technology in identified Asian territories. For more information, visit: http://www.visualant.net.

Sumitomo Precision Products Co., Ltd. is publicly traded on the Tokyo and Osaka Stock Exchanges and has operations in Japan, United States, China, United Kingdom, Canada, and other parts of the world. Additional information on SPP is available at http://www.spp.co.jp/English/index2-e.html

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2012/11/prweb10082808.htm

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Visualant, Inc.

CONTACT: NVPR
Hal Bringman
hal@nvpr.com
(323) 851-6877


 






International Provider
May 20, 2013 Burmese President's White House Visit a Reward for Reforms, FIND Government Press Releases
May 20, 2013 NC Attorney General pans Senate plan to restructure SBI, McClatchy-Tribune Information Services -- Unrestricted
May 20, 2013 Sustainable Energy Announces Extension of $1.5M Standby Equity Commitment by Doughty Hanson Technology Ventures, Marketwire
May 20, 2013 Kohler loses patent case, jury calls for firm to pay $9.6 million, McClatchy-Tribune Information Services -- Unrestricted
May 20, 2013 Sustainable Energy Announces Extension of $1.5M Standby Equity Commitment by Doughty Hanson Technology Ventures, Marketwire Canada
May 20, 2013 BRIEF: Rockville Bank Parent Approves Stock Repurchase, McClatchy-Tribune Information Services -- Unrestricted
May 20, 2013 FBR Announces Allen Morton Has Joined Investment Banking Team as Managing Director and Head of Houston Office, GlobeNewswire
May 20, 2013 Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference, CNW Group
May 20, 2013 Patheon Announces Date of Fiscal 2013 Second Quarter Financial Results, CNW Group
May 20, 2013 Memorial Production Partners LP Announces Pricing of a $100 Million Offering of Additional Senior Notes, GlobeNewswire
more...


 
MENAFN






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help